World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
66
Citations
20804
World Ranking
2360
National Ranking
959

Mark Holodniy publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Mark Holodniy sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 296 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Mark Holodniy D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Mark Holodniy sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 66 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Mark Holodniy is affiliated with Stanford University in the United States. Their research primarily spans the field of Medicine, with a significant focus on Infectious Diseases and Epidemiology. Their scholarly output includes numerous publications related to COVID-19 clinical research, SARS-CoV-2 studies, and respiratory viral infections.

Their research areas cover a range of topics including:

  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 and healthcare impacts
  • Long-Term Effects of COVID-19
  • Respiratory viral infections research
  • Vaccine Coverage and Hesitancy
  • Viral gastroenteritis research and epidemiology

Notable recent papers authored or co-authored by Holodniy include:

  • Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study (2020), published in PLoS Medicine
  • Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years (2020), published in bioRxiv (Cold Spring Harbor Laboratory)
  • Risk for In-Hospital Complications Associated with COVID-19 and Influenza - Veterans Health Administration, United States, October 1, 2018-May 31, 2020 (2020), published in MMWR Morbidity and Mortality Weekly Report
  • Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States Veterans (2020), published in bioRxiv (Cold Spring Harbor Laboratory)
  • Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial (2022), published in The Lancet Respiratory Medicine

Frequent co-authors in their work include:

  • Cynthia Lucero-Obusan
  • Gina Oda
  • Patricia Schirmer
  • Vincent C. Marconi
  • Maria C. Rodriguez-Barradas

Holodniy's publications are often featured in venues such as:

  • Open Forum Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • Infection Control and Hospital Epidemiology
  • MMWR Morbidity and Mortality Weekly Report

Their subfields of expertise include Infectious Diseases, Epidemiology, Neurology, Oncology, and Health, reflecting a broad yet focused approach to medical research.

Best Publications

  • A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

    M. N. Oxman;M. N. Oxman;M. J. Levin;G. R. Johnson;K. E. Schmader

  • Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

    David R. Bangsberg;Frederick M. Hecht;Edwin D. Charlebois;Andrew R. Zolopa

  • HIV-1 protease inhibitors. A review for clinicians.

    Steven G. Deeks;Mark Smith;Mark Holodniy;James O. Kahn

  • Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

    Gillian D. Sanders;Ahmed M. Bayoumi;Vandana Sundaram;Vandana Sundaram;S. Pinar Bilir

  • HIV viral load markers in clinical practice

    M S Saag;M Holodniy;D R Kuritzkes;W A O'Brien

  • Rapid identification of pathogenic bacteria using Raman spectroscopy and deep learning.

    Chi-Sing Ho;Neal Jean;Catherine A. Hogan;Lena Blackmon

  • Multifunctional coatings to simultaneously promote osseointegration and prevent infection of orthopaedic implants.

    Jordan Raphel;Mark Holodniy;Stuart B. Goodman;Sarah C. Heilshorn

  • siRNA Delivery into Human T Cells and Primary Cells with Carbon‐Nanotube Transporters

    Zhuang Liu;Mark Winters;Mark Holodniy;Hongjie Dai

  • Phylogeny of Zika Virus in Western Hemisphere, 2015.

    Robert S. Lanciotti;Amy J. Lambert;Mark Holodniy;Sonia Saavedra

  • SIMULTANEOUS GENOTYPING AND SPECIES IDENTIFICATION USING HYBRIDIZATION PATTERN RECOGNITION ANALYSIS OF GENERIC MYCOBACTERIUM DNA ARRAYS

    Thomas R. Gingeras;Ghassan Ghandour;Eugene Wang;Anthony Berno

  • High levels of adherence do not prevent accumulation of HIV drug resistance mutations.

    David R Bangsberg;Edwin D Charlebois;Robert M Grant;Mark Holodniy

  • Effect of Home Testing of International Normalized Ratio on Clinical Events

    David B. Matchar;Alan Jacobson;Rowena Dolor;Robert Edson

  • The Impact of Active Herpes Simplex Virus Infection on Human Immunodeficiency Virus Load

    Larry Mole;Stefan Ripich;Dan Margolis;Mark Holodniy

  • Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study.

    Christopher T Rentsch;Christopher T Rentsch;Farah Kidwai-Khan;Farah Kidwai-Khan;Janet P Tate;Janet P Tate;Lesley S Park

  • Inhibition of human immunodeficiency virus gene amplification by heparin.

    M. Holodniy;Sue Kim;D. Katzenstein;M. Konrad

  • Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4

    Theresa L.-Y. Chang;Chia-Hwa Chang;David A. Simpson;Qiang Xu

  • Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial.

    Miles McFall;Andrew J. Saxon;Carol A. Malte;Bruce Chow

  • Recombinant Soluble CD4 Therapy in Patients with the Acquired Immunodeficiency Syndrome (AIDS) and AIDS-Related Complex: A Phase I-II Escalating Dosage Trial

    Schooley Rt;Merigan Tc;Gaut P;Hirsch Ms

  • Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic Review

    Clay Bavinger;Eran Bendavid;Katherine Niehaus;Richard A. Olshen

  • New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis.

    Shan Liu;Lauren E Cipriano;Mark Holodniy;Douglas K Owens

Frequent Co-Authors

Mark A. Winters
Mark A. Winters Stanford University
Thomas C. Merigan
Thomas C. Merigan Stanford University
David Katzenstein
David Katzenstein Stanford University
Maria C. Rodriguez-Barradas
Maria C. Rodriguez-Barradas Baylor College of Medicine
Aslam H. Anis
Aslam H. Anis University of British Columbia
Aron J. Hall
Aron J. Hall Centers for Disease Control and Prevention
Umesh D. Parashar
Umesh D. Parashar Centers for Disease Control and Prevention
Mark Sculpher
Mark Sculpher University of York
Matthew Bidwell Goetz
Matthew Bidwell Goetz University of California, Los Angeles
Jan Vinjé
Jan Vinjé Centers for Disease Control and Prevention

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond traditional microbiology programs, pursuing related online degrees can open new career opportunities. For example, individuals seeking rapid entry into the healthcare field might consider the quickest medical billing and coding certificate online. This pathway offers vital skills for managing medical data and insurance processes, which are essential in healthcare administration.

Many students wonder about what medical degree can i get online. With growing demand for accessible education, options like nursing, public health, and other allied health fields are increasingly available through flexible online programs.

For those drawn to public health, exploring the online public health masters programs easy to get into can provide a practical route to advance your career without the stringent admission barriers of traditional MPH programs.

Additionally, careers such as a child life specialist offer meaningful ways to support pediatric patients through medical challenges, blending knowledge of biology, psychology, and patient care in specialized settings.

Best Scientists Citing Mark Holodniy

Trending Scientists

Recently Published Articles